The FDA said it requires Cameron Health to conduct a postmarket study to assess the long-term safety and performance of the device. Shares of Boston Scientific closed at $5.74 on Friday on the New York Stock Exchange.
In New York Stock Exchange trading, Boston Scientific's shares rose $1.30 to $45.60. The shares have gained 75% in the last year. In 1996, three years after Mann launched Advanced Bionics, the firm introduced its auditory implant for …
A Brazilian court has once again suspended a construction licence for Canada’s Belo Sun Mining’s (TSX:BSX) Volta Grande project ... But year-to-date, the stock is still up 1.47%. According to Brazilian regulations, indigenous studies …
Boston Scientific is headquartered in Natick, Mass., and acquired Guidant in 2006. The Justice Department said that while Guidant took corrective action to fix the defects, the company continued selling its remaining stock of defective …
Boston Scientific said sales of pacemakers dipped 4.5 percent to ... “We would certainly use this weakness (in the stock) as a significant buying opportunity,” Canaccord Genuity analyst Jason Mills said, adding it was a “very good quarter” for ...
What's next for the stock? We take a look at earnings estimates for some ... CME Group, Trimble Navigation, and Boston Scientific — Factors of Influence, Major Initiatives and Sustained Production NEW YORK, Feb. 21, 2018-- In new …
Among the companies with shares expected to trade actively in Thursday’s session are , and Boston Scientific is buying Swiss medical-device maker Symetis SA for $435 million cash. Shares of Boston Scientific fell 1.25% to $24.40 in …
Boston Scientific Corporation and Abbott Labs. To gain competitive advantage the major players adopt strategies such …
The "Global Surgical Equipment Market Analysis & Trends - Industry Forecast to 2025" report has been added to …
Boston Scientific's Subcutaneous Implantable Defibrillator (S-ICD) requires the wires to be implanted under the skin along the bottom of the rib cage, making the procedure accessible to more patients. It is the first such device to get approval …